Back

Prognostic implications of significant tricuspid regurgitation in patients with atrial fibrillation in the absence of left-sided heart disease or pulmonary hypertension

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Mitral and tricuspid Tricuspid Valve Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Ms Marlieke Dietz

Leiden University Medical Center, Leiden (Netherlands (The))

9 More presentations in this session

Presentation thumbnail
Identifying the ideal MitraClip candidate - a COAPT-derived, retrospective subgroup stratification of a large real-life cohort
Doctor E. Tigges (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Concordance and discordance among the recommended echocardiographic parameters for the assessment of mitral regurgitation severity
Doctor L. Gillam (Morristown, US)
Abstract
Presentation thumbnail
Changes in size of ascending aorta in patients with bicuspid aortic valves
Doctor V. Becerra Munoz (Malaga, ES)
Abstract
Presentation thumbnail
Quantitation of severe degenerative mitral regurgitation by echocardiography and CMR with acetate PET for external reference for left ventricular volumes
Associate Professor T. Baron (Uppsala, SE)
Abstract
Presentation thumbnail
Usefulness of multimodality imaging approach in the diagnosis of mechanical prosthetic valve dysfunction
Doctor L. Fusini (Milan, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Mitral and tricuspid

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources